Lucid Capital Markets Starts Tvardi Therapeutics Inc (TVRD) at Buy
Strong upside potential with new Buy rating.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Strong upside potential with new Buy rating.
What happened, with direct paths to the underlying reporting
Loop Capital starts TVRD at Buy; target $14; price $4.68; priceChangeSinceSignal -1.07.
Target: $14
Posted price: $4.68
Analyst firm: Loop Capital Markets
Analyst: Elemer Piros
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.